E
ONC

Ergoteles’s BeOne Medicines Ltd ONC Stock Holding History

Ergoteles’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,639
Closed -$2.77M – 1656
2021
Q3 		$2.77M Buy
7,639
+4,199
+122% +$1.37M 0.1% 218
2021
Q2 		$1.18M Sell
3,440
-13,904
-80% -$4.61M 0.03% 461
2021
Q1 		$6.04M Buy
+17,344
New +$5.74M 0.19% 143

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Ergoteles's ONC Position: Q4 2021 in Review

Ergoteles sold out of BeOne Medicines Ltd (ONC) in Q4 2021, closing a stake of 7,639 shares — an estimated $2.77M sold.

Ergoteles first reported a position in ONC in Q1 2021 and held it in 3 quarters. The position peaked at $6.04M in Q1 2021. 263 funds tracked by Wall St. Rank hold ONC as of Q4 2021.

  • Ergoteles reported no remaining BeOne Medicines Ltd position as of Q4 2021 after selling out during the quarter.
  • Ergoteles sold 7,639 BeOne Medicines Ltd shares in Q4 2021, an estimated $2.77M.
  • Ergoteles first reported a position in BeOne Medicines Ltd in Q1 2021 and held it in 3 quarters.
  • Ergoteles's BeOne Medicines Ltd position peaked at $6.04M in Q1 2021.
  • 263 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.